Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder
- PMID: 38866215
- DOI: 10.1016/j.lfs.2024.122815
Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder
Abstract
Major depressive disorder (MDD) is characterized by a high rate of recurrence and disability, which seriously affects the quality of life of patients. That's why a deeper understanding of the mechanisms of MDD pathology is an urgent task, and some studies have found that intestinal symptoms accompany people with MDD. The microbiota-gut-brain axis is the bidirectional communication between the gut microbiota and the central nervous system, which was found to have a strong association with the pathogenesis of MDD. Previous studies have focused more on the communication between the gut and the brain through neuroendocrine, neuroimmune and autonomic pathways, and the role of gut microbes and their metabolites in depression is unclear. Metabolites of intestinal microorganisms (e.g., tryptophan, kynurenic acid, indole, and lipopolysaccharide) can participate in the pathogenesis of MDD through immune and inflammatory pathways or by altering the permeability of the gut and blood-brain barrier. In addition, intestinal microbes can communicate with intestinal neurons and glial cells to affect the integrity and function of intestinal nerves. However, the specific role of gut microbes and their metabolites in the pathogenesis of MDD is not well understood. Hence, the present review summarizes how gut microbes and their metabolites are directly or indirectly involved in the pathogenesis of MDD.
Keywords: Fecal microbiota transplantation; Intestinal permeability; Major depressive disorder; Microbial metabolite; Microbiota-gut-brain axis.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no conflict of interest to declare.
Similar articles
-
Research Progress on Mechanisms of Modulating Gut Microbiota to Improve Symptoms of Major Depressive Disorder.Discov Med. 2024 Jul;36(186):1354-1362. doi: 10.24976/Discov.Med.202436186.125. Discov Med. 2024. PMID: 39054706 Review.
-
Major Depressive Disorder and gut microbiota - Association not causation. A scoping review.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110111. doi: 10.1016/j.pnpbp.2020.110111. Epub 2020 Sep 23. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32976952
-
Relationships between the gut microbiome and brain functional alterations in first-episode, drug-naïve patients with major depressive disorder.J Affect Disord. 2024 Oct 1;362:578-584. doi: 10.1016/j.jad.2024.07.013. Epub 2024 Jul 6. J Affect Disord. 2024. PMID: 38972643
-
Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.Harv Rev Psychiatry. 2020 Jan/Feb;28(1):26-39. doi: 10.1097/HRP.0000000000000243. Harv Rev Psychiatry. 2020. PMID: 31913980 Free PMC article. Review.
-
Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers.Transl Psychiatry. 2018 Jan 31;8(1):34. doi: 10.1038/s41398-017-0078-2. Transl Psychiatry. 2018. PMID: 29382834 Free PMC article.
Cited by
-
Rethinking Depression-Beyond Neurotransmitters: An Integrated Psychoneuroendocrineimmunology Framework for Depression's Pathophysiology and Tailored Treatment.Int J Mol Sci. 2025 Mar 19;26(6):2759. doi: 10.3390/ijms26062759. Int J Mol Sci. 2025. PMID: 40141399 Free PMC article. Review.
-
The Biology and Biochemistry of Kynurenic Acid, a Potential Nutraceutical with Multiple Biological Effects.Int J Mol Sci. 2024 Aug 21;25(16):9082. doi: 10.3390/ijms25169082. Int J Mol Sci. 2024. PMID: 39201768 Free PMC article. Review.
-
Recent advances in therapeutic probiotics: insights from human trials.Clin Microbiol Rev. 2025 Jun 12;38(2):e0024024. doi: 10.1128/cmr.00240-24. Epub 2025 Apr 22. Clin Microbiol Rev. 2025. PMID: 40261032 Review.
-
Schaftoside Reduces Depression- and Anxiogenic-like Behaviors in Mice Depression Models.Brain Sci. 2025 Feb 24;15(3):238. doi: 10.3390/brainsci15030238. Brain Sci. 2025. PMID: 40149760 Free PMC article.
-
Investigating the modulatory effects of lactoferrin on depressed rats through 16S rDNA gene sequencing and LC-MS metabolomics analysis.Sci Rep. 2024 Sep 27;14(1):22111. doi: 10.1038/s41598-024-72793-2. Sci Rep. 2024. PMID: 39333605 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources